Trially
4 known investors
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment. The platform targets research sites and trial sponsors seeking to reduce screening time and trial delays through HIPAA-compliant patient data analysis.
Founders & leadership
KM
Kyle McAllisterCEO & Founder
Investors · 4
In the news
- Trially AI: $4.7 Million Raised For AI-Based Clinical Trial Recruitment Platformpulse2.com · 2025
- Trially AI Raises $4.7M Seed Round, Launches AI for Clinical Trial Enrollmentbiopharmatrend.com · 2025
- Trially AI Raises $4.7M in Seed Fundingfinsmes.com · 2025
- Trially raises $4.7m to enhance trial recruitment with AIclinicaltrialsarena.com · 2025
- Trially secures $4.7M seed round, launches ‘Margo’ AI solution to clear patient bottleneck - Startland Newsstartlandnews.com · 2025
- Why We Invested In Trially. Trially is revolutionizing the clinical… | by Brett Calhoun | Redbud VC | Mediummedium.com · 2024